Quality assurance of MRI-guided radiotherapy systems

We will delve into the world of MRI-guided radiotherapy systems and the critical role of quality assurance in delivering precise, personalized cancer treatments.

This webinar will address the unique challenges and considerations that MRgRT QA presents. From image distortion and system calibration to complex workflows, understanding and mitigating these challenges is vital for every healthcare professional working with MRgRT systems. Moreover, the webinar will delve into well-established quality assurance protocols and procedures that are tailored specifically to MRI-guided radiotherapy systems.

All facets of quality assurance, spanning machine QA, patient-specific QA, and real-time adaptive QA, will come under thorough scrutiny and discussion throughout the session.

Stephanie Tanadini-Lang is co-vice chair of the department of radiation oncology at the University Hospital Zurich in Switzerland. She is also head of medical physics at the hospital, where she is responsible for all dosimetric aspects of 1700 patients per year in the radiation oncology department, and is group leader of the radiomics and modelling research team. After studying for a MPhys at the University of Constance in Germany, Stephanie obtained a MAS in medical physics from ETH Zurich and a PhD in medical physics from the University of Zurich. Her research to date has included studies of quality assurance for complex radiosurgery, radiomics for non-small cell lung cancer, quantitative image analysis in glioblastoma, deep learning algorithms and synthetic CT images.